Section 5.5 of the article<unk>  in volume 66 of the World Health Organization's (WHO) and International Agency for Research on Cancer's (IARC) IARC Monographs On The Evaluation Of Carcinogenic Risks To Humans, an article describing the carcinogenic/toxic effects of<unk>  on humans and experimental animals, states that there is "inadequate evidence in humans for the carcinogenicity of<unk> " and limited evidence in experimental for the carcinogenicity of<unk> ," and concluded that the overall evaluation of the substance's carcinogenicity to humans is "not classifiable."
Doxefazepam
Diclazepam
Gidazepam
Oxazepam
Halazepam
Triazolam
Quazepam
Cinolazepam